Vasoactive Peptides in Portal Pressure

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study is looking at the detection of vasoactive peptides in portal hypertension.

• Phase: N/A

Details

• Lead Sponsor: Bayside Health
• Treatments: Norfloxacin

Criteria

Inclusion Criteria:

• HVPG >= 12 mmHg